Experiment 394718

Worktypes

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismGinkgo biloba (GINKGOACEAE)
CitationCLAUSSEN,CF: KIRTANE,MV:. (1985). RANDOMIZED DOUBLE-BLIND STUDY OF THE EFFECT OF GINKGO BILOBA EXTRACT ON DIZZINESS AND UNSTEADY GAIT IN THE ELDERLY.. 1985()
Amount utilized
Compound isolated
DiseaseTHE THERAPEUTIC EFFECT OF GINKGO BILOBA WAS EVALUATED IN A DOUBLE BLIND TRAIL VERUS PLACEBO BY MEAN OF CRANIO-CORPOGRAPHY(CCG) AND DIRECT QUESTIONING OF 33 ELDERLY PATIENTS (17 MALES, AGED 51-71 YEARS, MEAN AGE 59.1 + 5.0 YEARS; 16 FEMALES, AGED 50-59 YEARS, MEAN AGE 59.2+2.8 YEARS) WITH EXISTING SYMPTOMS OF VERTIGO AND ATAZIA. CGG WAS CARRIED OUT BEFORE BEGINNING OF THE TREATMENT, AND AFTER 6 WEEKS AND 12 WEEKS OF TREATMENT WITH 120 MG/DAY OF GINKGO EXTRACT OR 3 DRAGEES OF PLACEBO PER DAY. WITH THE GINKGO BILOBA TREATMENT, THE CCG SHOWED A STATISTICALLY SIGNIFICANT DECREASE IN THE LATERAL SWAY AMPLITUDE IN THE "STEPPING ON THE SPOT" TEST (BY UNTER-BERGER). ON DIRECT QUESTIONING, 20% OF THE PATIENTS IN THE PLACEBO GROUP AND 50% OF THE PATIENTS IN THE GINKGO BILOBA GROUP REPORTED ON A SUBJECTIVE DECREASE OF THEIR VERTIGO SYMPTOMS. EGB-761 WAS USED. NO SIDE EFFECTS WERE OBSERVED DURING THE WHOLE COURSE OF TREATMENT.
Dose amount120.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractETOH(100%)EXT
GenderGIVEN TO BOTH SEXES